Literature DB >> 3594390

Selecting initial therapy for prostate cancer. Radiation therapy perspective.

M A Bagshaw, G R Ray, R S Cox.   

Abstract

External-beam irradiation of prostatic cancer was introduced at Stanford in 1956. The program has sought to determine the following: whether prostatic carcinoma can be cured by external beam radiation therapy, with what frequency this can be accomplished, which patients are best suited for irradiation, and what technique best accomplishes the irradiation. This report deals with differences and similarities between radiation therapy and surgery, and emphasizes the selection of patients for irradiation.

Entities:  

Mesh:

Year:  1987        PMID: 3594390     DOI: 10.1002/1097-0142(19870801)60:3+<521::aid-cncr2820601514>3.0.co;2-r

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  2 in total

1.  Prostate-specific antigen as a marker of adenocarcinoma of prostate.

Authors:  P Kellokumpu-Lehtinen; M Nurmi; P Koskinen; K Irjala
Journal:  Urol Res       Date:  1989

2.  Iridium 192 high-dose-rate brachytherapy--a useful alternative therapy for localized prostate cancer?

Authors:  R Paul; R Hofmann; J U Schwarzer; R Stepan; H J Feldmann; P Kneschaurek; M Molls; R Hartung
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.